Skip to content

Effect of Jadwar capsules in multiple sclerosis patients

Clinical evaluation of the effect of Jadwar (Delphinium denudatum) capsules on quality of life and fatigue of multiple sclerosis patients

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200128046288N5
Enrollment
60
Registered
2020-11-19
Start date
2020-12-21
Completion date
Unknown
Last updated
2020-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Multiple sclerosis. Condition 2: Fatigue. Multiple sclerosis Fatigue

Interventions

Intervention 1: Intervention group: Capsule of Jadwar 500 mg once daily for three months. Intervention 2: Control group: Capsule of placebo once daily for three months.

Sponsors

Ahvaz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 65 Years

Inclusion criteria

Inclusion criteria: MS has been proven by clinical examinations and medical history Having stable and regular drug treatment in the last 4 weeks No new attack in last month Having a score of EDSS disability assessment between 2 to 5.5

Exclusion criteria

Exclusion criteria: Pregnancy and lactation Renal and hepatic dysfunction Neurologic disease in addition to MS Cardiovascular disease or infectious disease Allergy to Jadwar

Design outcomes

Primary

MeasureTime frame
Fatigue rate. Timepoint: The first day of intervention and three months later. Method of measurement: FSS questionnaires.;Quality of Life. Timepoint: The first day of intervention and three months later. Method of measurement: Questionnaire MSQL54.

Secondary

MeasureTime frame
Side effects of the drug. Timepoint: Three months after the start of the intervention. Method of measurement: Observation.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFereshteh Golfakhrabadi

Ahvaz University of Medical Sciences

golfakhrabadi@yahoo.com+98 61 3373 8378

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026